# Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients

> **NCT00982995** · PHASE2 · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Nausea
- Vomiting
- Terminally Ill

## Interventions

- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT00982995
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** site terminated due to lack of enrollment
- **Last updated:** 2015-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982995, "Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00982995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*